Bronchogen
Also known as: AEDG peptide, Ala-Glu-Asp-Gly
Clinical Status
Preclinical — Russian bioregulator research.
Mechanism of Action
A tetrapeptide bioregulator that targets bronchial and pulmonary tissue. Modulates gene expression in respiratory epithelial cells, promotes repair of damaged bronchial mucosa, and has anti-inflammatory effects in lung tissue.
Dosing Defaults
Dose
10 mg
Frequency
1x daily
Administration
Oral capsule
Timing
Morning
Food
fasted
Duration
10-20 day cycles
Dose range: 5-20 mg daily
Morning dosing supports respiratory function during the day.
Side Effects
- •Mild GI discomfort
- •Headache
- •Cough (transient)
Contraindications & Warnings
- •Not medical advice
- •Limited Western clinical data
Compare
Compare Bronchogen with another peptide side-by-side.
Ad
Related Anti-Aging & Longevity Peptides
This information is for educational purposes only and is not medical advice. Dosing data is based on research literature and community reports. Always consult a qualified healthcare provider before using any peptide.